These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4397188)

  • 1. The effect of additives on the release of drug from hard gelatin capsules.
    Newton JM; Rowley G; Törnblom JF
    J Pharm Pharmacol; 1971 Jun; 23(6):452-3. PubMed ID: 4397188
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on the effect of additives on the release of drug from hard gelatin capsules.
    Newton JM; Rowley G; Törnblom JF
    J Pharm Pharmacol; 1971 Dec; 23():156S-160S. PubMed ID: 4401451
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of additives on the presentation of a drug in hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of lithium and magnesium from lithium carbonate capsules containing magnesium stearate.
    Caldwell HC
    J Pharm Sci; 1974 May; 63(5):770-3. PubMed ID: 4830001
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of additives on the in vitro release of drugs from hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():30P-36P. PubMed ID: 4156731
    [No Abstract]   [Full Text] [Related]  

  • 7. Further observations on an outbreak of diphenylhydantoin intoxication.
    Tyrer JH; Eadie MJ; Hooper WD
    Proc Aust Assoc Neurol; 1971; 8():37-41. PubMed ID: 4341120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
    Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB
    Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of particle size of rifampicin and addition of magnesium stearate on release of rifampicin from hard gelatin capsules (author's transl)].
    Nakagawa H; Mohri K; Nakashima K; Sugimoto I
    Yakugaku Zasshi; 1980 Nov; 100(11):1111-7. PubMed ID: 7205556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of sliding agents on the rate of dissolution of acetylsalicylic acid in gel capsules].
    Merle C; Artaud M; Guyot-Hermann AM
    Farmaco Prat; 1979 May; 34(5):210-9. PubMed ID: 456558
    [No Abstract]   [Full Text] [Related]  

  • 11. On the release of drug from hard gelatin capsules.
    Newton JM; Rowley G
    J Pharm Pharmacol; 1970 Dec; ():Suppl:163S+. PubMed ID: 4395574
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of starch and lactose on the release rates of drugs from hard gelatin capsules.
    Davies JE; Fell JT
    J Pharm Pharmacol; 1973 May; 25(5):431-2. PubMed ID: 4146407
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro bioavailability of various drugs formulated as hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 Apr; 29(4):205-8. PubMed ID: 17668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of tablets. IV. Influence of the nature and proportion of some adjuvants on phenobarbital grain and tablet qualities].
    Clerc J; Duchêne D; Puisieux F
    Ann Pharm Fr; 1970 Dec; 28(12):719-28. PubMed ID: 5516406
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of drug and diluent particle size on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1980 Mar; 32(3):167-71. PubMed ID: 6103930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution from several experimental capsule formulations.
    Samyn JC; Jung WY
    J Pharm Sci; 1970 Feb; 59(2):169-75. PubMed ID: 5411338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medicinal capsules].
    Khanina GI; Batkina ZV; Pospelova VV; Dedukh NG
    Farmatsiia; 1974; (6):67-70. PubMed ID: 4618815
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of preservatives with surface-active and high-molecular substances].
    Pertsev IV; Bashura GS; Dmitrievskiĭ DI; Pilipenko MK; Sadovnichiĭ IuO
    Farm Zh; 1973; 28(5):19-27. PubMed ID: 4603638
    [No Abstract]   [Full Text] [Related]  

  • 20. Some factors affecting release and availability of drugs from hard gelatin capsules.
    McGee BJ; Kennedy DR; Walker GC
    J Pharm Sci; 1970 Oct; 59(10):1430-3. PubMed ID: 5471949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.